About 8,520,000 results
Open links in new tab
FDA approves neoadjuvant/adjuvant nivolumab for resectable …
Perioperative Opdivo Extends Event-Free Survival in Lung Cancer
Neoadjuvant/Adjuvant Opdivo Approved for Resectable NSCLC
Nivolumab NSCLC Approval Expanded to Perioperative Setting
FDA Approves Perioperative Nivolumab for Resectable NSCLC
U.S. Food and Drug Administration Approves Opdivo®(nivolumab…
FDA approves nivolumab in combination with cisplatin and …
Bristol Myers Squibb - U.S. Food and Drug Administration Accepts ...
FDA approves nivolumab for adjuvant treatment of Stage IIB/C …
Researchers build first large-scale atlas of how immune cells react …